Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2025-07-03 13:04 Tx date 2025-06-30 |
$HLS
HLS Therapeutics Inc. |
Dempsey, Kyle Edward
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$40,129
+8,343 vol $4.81 each |
111,838 | |
Filed 2025-04-01 12:06 Tx date 2025-03-31 |
$HLS
HLS Therapeutics Inc. |
Dempsey, Kyle Edward
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$42,055
+9,243 vol $4.55 each |
103,495 | |
Filed 2025-01-03 15:27 Tx date 2024-12-31 |
$HLS
HLS Therapeutics Inc. |
Dempsey, Kyle Edward
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$43,716
+11,596 vol $3.77 each |
94,252 | |
Filed 2024-10-03 09:54 Tx date 2024-09-30 |
$HLS
HLS Therapeutics Inc. |
Dempsey, Kyle Edward
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$37,142
+10,204 vol $3.64 each |
82,656 | |
Filed 2024-07-05 10:22 Tx date 2024-06-30 |
$HLS
HLS Therapeutics Inc. |
Dempsey, Kyle Edward
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$37,639
+11,038 vol $3.41 each |
72,452 | |
Filed 2024-04-01 14:11 Tx date 2024-03-31 |
$HLS
HLS Therapeutics Inc. |
Dempsey, Kyle Edward
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$37,262
+9,806 vol $3.80 each |
61,414 | |
Filed 2024-03-25 13:48 Tx date 2024-03-25 |
$HLS
HLS Therapeutics Inc. |
Dempsey, Kyle Edward
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$203,114
+49,783 vol $4.08 each |
51,608 | |
Filed 2022-12-16 16:07 Tx date 2022-12-12 |
$HLS
HLS Therapeutics Inc. |
Dempsey, Kyle Edward
4 - Director of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
$18,450
+1,825 vol $10.11 each |
1,825 | |
Filed 2022-12-16 16:06 Tx date 2022-11-28 |
$HLS
HLS Therapeutics Inc. |
Dempsey, Kyle Edward
4 - Director of Issuer
Direct Ownership
|
DSU
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-12-05 13:02 Tx date 2022-11-28 |
$HLS
HLS Therapeutics Inc. |
Dempsey, Kyle Edward
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,765 |